Intravesical Chemotherapy

DRUG2 trials

Sponsors

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Hamlet Pharma AB

Conditions

Non-Muscle-Invasive Bladder CancerNon-muscle Invasive Bladder Cancer (NMIBC)Urinary Bladder Neoplasms

Phase 3

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

Not yet recruitingNCT06327932

Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNon-Muscle-Invasive Bladder Cancer

Start: 2024-04-01End: 2028-03-31Target: 320Updated: 2024-03-25

A Study to Investigate the Efficacy and Safety of Alpha1H as a Neoadjuvant Therapy in Participants With Low- to Intermediate-Risk/Low-Grade Papillary Non-Muscle Invasive Bladder Cancer

Not yet recruitingNCT07804056

Hamlet Pharma ABNon-muscle Invasive Bladder Cancer (NMIBC), Urinary Bladder Neoplasms

Start: 2026-09-01End: 2029-07-01Target: 194Updated: 2026-09-04